Equities research analysts expect Esperion Therapeutics, Inc. (NASDAQ:ESPR) to report $18.90 million in sales for the current quarter, Zacks reports. Four analysts have provided estimates for Esperion Therapeutics’ earnings, with the lowest sales estimate coming in at $7.75 million and the highest estimate coming in at $50.00 million. Esperion Therapeutics posted sales of $980,000.00 in […]
